Active, not recruitingPhase 3NCT05600426
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
Studying Aplastic Anemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- David Williams, MDBoston Children's Hospital
- Intervention
- cyclosporine(drug)
- Enrollment
- 53 enrolled
- Eligibility
- 0-25 years · All sexes
- Timeline
- 2023 – 2029
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Arkansas, Little Rock, Arkansas, United States
- Loma Linda, Loma Linda, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- UCLA, Los Angeles, California, United States
- Children's Hospital & Research Center Oakland, Oakland, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Stanford, Palo Alto, California, United States
- Rady Children's Hospital San Diego, San Diego, California, United States
- University of California San Francisco, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Yale University, New Haven, Connecticut, United States
- Nemours Children's Hospital, Delaware, Wilmington, Delaware, United States
- Children's National Hospital, Washington D.C., District of Columbia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Center for International Blood and Marrow Transplant Research · National Institutes of Health (NIH) · National Heart, Lung, and Blood Institute (NHLBI) · North American Pediatric Aplastic Anemia Consortium · Pediatric Transplantation and Cellular Therapy Consortium · Blood and Marrow Transplant Clinical Trials Network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05600426 on ClinicalTrials.govOther trials for Aplastic Anemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07461116Adverse Effects of ATG/ALG Therapy in Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT07400341Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AAThe First Affiliated Hospital of Soochow University
- RECRUITINGNANCT07101770A Prediction Model in Pregnant Women With Aplastic AnemiaPeking University People's Hospital
- RECRUITINGNANCT07499284A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic AnemiaThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE2NCT06752694Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic AnemiaFred Hutchinson Cancer Center
- RECRUITINGPHASE1NCT06622694CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT06517641Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic AnemiaMedical College of Wisconsin
- RECRUITINGNANCT06936930Reproductive and Mental Health of Patients With Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China